Yasunaga, S. et al. A mutation in OTOF, encoding otoferlin, a FER-1-like protein, causes DFNB9, a nonsyndromic form of deafness. Nat. Genet. 21, 363–369 (1999).
Google Scholar
Lv, J. et al. AAV1-hOTOF gene therapy for autosomal recessive deafness 9: a single-arm trial. Lancet 403, 2317–2325 (2024).
Google Scholar
Wang, H. et al. Bilateral gene therapy in children with autosomal recessive deafness 9: single-arm trial results. Nat. Med. 30, 1898–1904 (2024).
Google Scholar
Cheng, X. et al. Gene therapy vs cochlear implantation in restoring hearing function and speech perception for individuals with congenital deafness. JAMA Neurol. 82, 941–951 (2025).
Google Scholar
Qi, J. et al. AAV gene therapy for autosomal recessive deafness 9: a single-arm trial. Nat. Med. 31, 2917–2926 (2025).
Google Scholar
Morton, C. C. & Nance, W. E. Newborn hearing screening—a silent revolution. N. Engl. J. Med. 354, 2151–2164 (2006).
Google Scholar
Lieu, J. E. C., Kenna, M., Anne, S. & Davidson, L. Hearing loss in children: a review. JAMA 324, 2195–2205 (2020).
Google Scholar
Sloan-Heggen, C. M. et al. Comprehensive genetic testing in the clinical evaluation of 1119 patients with hearing loss. Hum. Genet. 135, 441–450 (2016).
Google Scholar
Rodríguez-Ballesteros, M. et al. A multicenter study on the prevalence and spectrum of mutations in the otoferlin gene (OTOF) in subjects with nonsyndromic hearing impairment and auditory neuropathy. Hum. Mutat. 29, 823–831 (2008).
Google Scholar
Iwasa, Y. I. et al. OTOF mutation analysis with massively parallel DNA sequencing in 2,265 Japanese sensorineural hearing loss patients. PLoS ONE 14, e0215932 (2019).
Google Scholar
Choi, B. Y. et al. Identities and frequencies of mutations of the otoferlin gene (OTOF) causing DFNB9 deafness in Pakistan. Clin. Genet. 75, 237–243 (2009).
Google Scholar
Akil, O. et al. Dual AAV-mediated gene therapy restores hearing in a DFNB9 mouse model. Proc. Natl Acad. Sci. USA 116, 4496–4501 (2019).
Google Scholar
Zhang, Q. J. et al. High frequency of OTOF mutations in Chinese infants with congenital auditory neuropathy spectrum disorder. Clin. Genet. 90, 238–246 (2016).
Google Scholar
Roux, I. et al. Otoferlin, defective in a human deafness form, is essential for exocytosis at the auditory ribbon synapse. Cell 127, 277–289 (2006).
Google Scholar
Zhang, L. et al. Preclinical evaluation of the efficacy and safety of AAV1-hOTOF in mice and nonhuman primates. Mol. Ther. Methods Clin. Dev. 31, 101154 (2023).
Google Scholar
Reisinger, E. & Trapani, I. Gene therapy proves successful in treating hereditary deafness. Lancet 403, 2267–2269 (2024).
Google Scholar
Necula, V. et al. Vertigo associated with otosclerosis and stapes surgery—a narrative review. Medicina 59, 1485 (2023).
Google Scholar
Quatre, R., Eklöf, M., Wales, J. & Bonnard, Å Long-term hearing outcomes following cochlear implantation in far advanced otosclerosis. Otolaryngol. Head Neck Surg. 172, 2065–2071 (2025).
Google Scholar
Terry, B., Kelt, R. E. & Jeyakumar, A. Delayed complications after cochlear implantation. JAMA Otolaryngol. Head Neck Surg. 141, 1012–1017 (2015).
Google Scholar
Keithley, E. M. Pathology and mechanisms of cochlear aging. J. Neurosci. Res. 98, 1674–1684 (2020).
Google Scholar
Ford, C. L. et al. The natural history, clinical outcomes, and genotype–phenotype relationship of otoferlin-related hearing loss: a systematic, quantitative literature review. Hum. Genet. 142, 1429–1449 (2023).
Google Scholar
Paping, D. E. et al. Distortion product otoacoustic emissions in screening for early stages of high-frequency hearing loss in adolescents. Noise Health 24, 20–26 (2022).
Google Scholar
Goutman, J. D., Elgoyhen, A. B. & Gomez-Casati, M. E. Cochlear hair cells: the sound-sensing machines. FEBS Lett. 589, 3354–3361 (2015).
Google Scholar
Farinetti, A., Raji, A., Wu, H., Wanna, B. & Vincent, C. International consensus (ICON) on audiological assessment of hearing loss in children. Eur. Ann. Otorhinolaryngol. Head Neck Dis. 135, S41–S48 (2018).
Google Scholar
Maddox, R. K. & Lee, A. K. C. Auditory brainstem responses to continuous natural speech in human listeners. eNeuro https://doi.org/10.1523/ENEURO.0441-17.2018 (2018).
Google Scholar
Gransier, R., Hofmann, M., van Wieringen, A. & Wouters, J. Stimulus-evoked phase-locked activity along the human auditory pathway strongly varies across individuals. Sci. Rep. 11, 143 (2021).
Google Scholar
Abdala, C. & Visser-Dumont, L. Distortion product otoacoustic emissions: a tool for hearing assessment and scientific study. Volta Rev. 103, 281–302 (2001).
Google Scholar
World Health Organization. World Report on Hearing (World Health Organization, 2021).
Robbins, A. M., Renshaw, J. J. & Berry, S. W. Evaluating meaningful auditory integration in profoundly hearing-impaired children. Am. J. Otol. 12, 144–150 (1991).
Google Scholar
Robbins, A. M. & Osberger, M. J. Meaningful Use of Speech Scale (MUSS) (Indiana University School of Medicine, 1990).
Pennini, P. T. M. & Almeida, K. Speech, Spatial and Qualities of Hearing Scale in assessing the benefit in hearing aid users. Codas 33, e20190196 (2021).
Google Scholar
Galvin, K. L. & Noble, W. Adaptation of the speech, spatial, and qualities of hearing scale for use with children, parents, and teachers. Cochlear Implants Int. 14, 135–141 (2013).
Google Scholar
Archbold, S., Lutman, M. E. & Nikolopoulos, T. Categories of auditory performance: inter-user reliability. Br. J. Audiol. 32, 7–12 (1998).
Google Scholar
McDaniel, D. M. & Cox, R. M. Evaluation of the Speech Intelligibility Rating (SIR) test for hearing aid comparisons. J. Speech Hear. Res. 35, 686–693 (1992).
Google Scholar
Fu, Q. J., Zhu, M. & Wang, X. Development and validation of the Mandarin speech perception test. J. Acoust. Soc. Am. 129, EL267-273 (2011).
Google Scholar
Cheng, X. et al. Music training can improve music and speech perception in pediatric Mandarin-speaking cochlear implant users. Trends Hear. 22, 2331216518759214 (2018).
Google Scholar
